These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29173673)

  • 1. Ventricular Arrhythmias.
    Dresen WF; Ferguson JD
    Cardiol Clin; 2018 Feb; 36(1):129-139. PubMed ID: 29173673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study.
    Farré J; Cabrera JA; Romero J; Rubio JM
    Am J Cardiol; 2000 Nov; 86(9A):44K-51K. PubMed ID: 11084100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatment of ventricular arrhythmias: state of the art.
    Stevenson WG
    Heart Rhythm; 2013 Dec; 10(12):1919-26. PubMed ID: 24120875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained ventricular tachycardia in structural heart disease.
    Hadid C
    Cardiol J; 2015; 22(1):12-24. PubMed ID: 25299497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter ablation for ventricular tachycardia.
    Lim HS; Singleton CB; Alasady M; McGavigan AD
    Intern Med J; 2010 Oct; 40(10):673-81. PubMed ID: 20214693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
    Patel C; Yan GX; Kocovic D; Kowey PR
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081
    [No Abstract]   [Full Text] [Related]  

  • 11. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.
    Al-Khatib SM; Daubert JP; Anstrom KJ; Daoud EG; Gonzalez M; Saba S; Jackson KP; Reece T; Gu J; Pokorney SD; Granger CB; Hess PL; Mark DB; Stevenson WG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):151-7. PubMed ID: 25332150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-pharmacological management of ventricular tachycardia.
    Chinushi M; Aizawa Y
    Circ J; 2007; 71 Suppl A():A97-105. PubMed ID: 17587747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden death risk in syncope: the role of the implantable cardioverter defibrillator.
    Olshansky B; Sullivan RM
    Prog Cardiovasc Dis; 2013; 55(4):443-53. PubMed ID: 23472783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnosis and management of ventricular arrhythmias.
    Roberts-Thomson KC; Lau DH; Sanders P
    Nat Rev Cardiol; 2011 Jun; 8(6):311-21. PubMed ID: 21343901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ESC guidelines 2015 for ventricular arrhythmias and prevention of sudden cardiac death. What is new?].
    Fink T; Kuck KH; Metzner A;
    Herz; 2015 Dec; 40(8):1034-42. PubMed ID: 26626552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 18. Ventricular Arrhythmias in Cardiac Sarcoidosis.
    Okada DR; Smith J; Derakhshan A; Gowani Z; Misra S; Berger RD; Calkins H; Tandri H; Chrispin J
    Circulation; 2018 Sep; 138(12):1253-1264. PubMed ID: 30354431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular tachycardia and sudden cardiac death.
    Koplan BA; Stevenson WG
    Mayo Clin Proc; 2009 Mar; 84(3):289-97. PubMed ID: 19252119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular arrhythmias and sudden cardiac death.
    John RM; Tedrow UB; Koplan BA; Albert CM; Epstein LM; Sweeney MO; Miller AL; Michaud GF; Stevenson WG
    Lancet; 2012 Oct; 380(9852):1520-9. PubMed ID: 23101719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.